Old age, left bundle branch block and acute myocardial infarction: a vexing and lethal combination∗∗Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  by Friesinger, Gottlieb C & Smith, Raphael F
EDITORIAL COMMENT
Old Age, Left Bundle
Branch Block and Acute
Myocardial Infarction:
A Vexing and Lethal
Combination*
Gottlieb C. Friesinger, II, MD, MACC,
Raphael F. Smith, MD, FACC
Nashville, Tennessee
The evolution of reperfusion therapy in the treatment of
acute myocardial infarction (AMI) has highlighted the
extraordinary importance of rapid and accurate diagnosis of
infarcts due to thrombosis of a major epicardial vessel, the
so-called Q-Wave Myocardial Infarction or Transmural
Myocardial Infarction. The presence of AMI can be estab-
lished by a wide variety of diagnostic tests, but the narrow
temporal window for significant myocardial salvage with
reperfusion dictates that the clinical presentation and the
12-lead ECG remain the principal tools available to make
the decision about reperfusion therapy. Although reperfu-
sion therapy has been embraced enthusiastically for treat-
ment of all ST segment elevation AMI, the benefit is
greatest in those subsets of patients with the highest
absolute risk for mortality, anterior myocardial infarction
and subsets of inferior infarction and other locations (1,2).
In subsets of very-low-risk infarcts, mortality benefit for
reperfusion therapy is marginal or has not been demon-
strated (3).
Age is a powerful determinant of outcome (4–7). The
mortality risk of AMI increases almost logarithmically with
age and 70% of fatal infarcts occur in patients over the age
of 65 years. These well-known features concerning AMI
and reperfusion therapy make the observational study of
Shlipak et al. (8), concerning the treatment and outcomes of
left bundle branch block (LBBB) in patients with AMI
reported in this issue of the Journal, of particular interest.
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Regardless of the changes and improvements in the logistics
of therapy in AMI, better outcomes will always be contin-
gent on prompt recognition of the patients who are candi-
dates for reperfusion therapy, particularly those at high risk.
The current study. The National Registry of Myocardial
Infarction 2 (NRMI-2) is a voluntary prospective observa-
tional registry of 772,586 patients with AMI admitted to
1,470 hospitals in all 50 states in the U.S. (8). The data were
collected between 1994 and 1998. This rich database
describes contemporary practice and provides information
on an extraordinary subset of 29,585 patients with LBBB
and AMI. This huge sample of LBBB patients constitutes
3.7% of the total NRMI-2 infarct population. In keeping
with the fact that LBBB is often associated with large
anterior myocardial infarctions and the mean age of these
patients was 76.4 years, the mortality rate of 22%, was
extremely high. Other notable attributes of the sample
include a high prevalence of major co-morbidity; congestive
heart failure in nearly 40%, diabetes in 37% and hyperten-
sion in over half of the sample population. Not surprising in
light of the advanced age, half of the sample population
were female in contrast to the gender mix in younger subsets
of AMI in which male patients predominate.
A particularly important feature is the extremely low
utilization of reperfusion therapy; only 8.4% of the sample
population had any form of reperfusion. Since the absolute
benefit (e.g., number needed to treat to prevent one death or
number of lives saved per thousand patients treated) of
reperfusion therapy is greatest in the infarcts of highest risk,
this is a particularly disturbing characteristic of contempo-
rary practice. The investigators’ analyses provide important
explanations for the phenomenon of failure to treat. Nearly
half of the patients (47%) presented without chest pain. The
absence of chest pain (ischemic discomfort) is a frequent
feature in elderly patients with AMI (9–12). Although no
data related to the actual presenting complaints are given, it
is reasonable to assume that the majority had dyspnea, the
common presenting complaint in elderly patients with
AMI.
The combination of a nondiagnostic ECG (LBBB) and
the absence of chest pain undoubtedly discouraged the use
of reperfusion therapy in this very high-risk population. An
extremely small proportion, 2.6%, without chest pain re-
ceived reperfusion therapy. However, only 13.6% of patients
with chest pain received reperfusion therapy. Other treat-
ment and diagnostic procedures were used significantly less
often in the non–chest pain group: aspirin, 73% versus 55%;
beta-blocker, 33% versus 18%; heparin, 69% versus 48%;
elective coronary arteriography, 33% versus 16%; elective
percutaneous transluminal coronary angioplasty, 12% vs.
4%; and elective coronary artery bypass; 6% vs. 3%. Only
angiotensin-converting enzyme inhibitors were used with
equal frequency (30% vs. 32%). Left bundle branch block
was found in 2.7% of patients with AMI ,65 years of age
and in 10.5% in those .75 years old. In the LBBB-AMI
group, 37% ,65 years presented with chest pain, while 50%
of those .75 years had no chest discomfort.
In a larger context, the LBBB-AMI group reflects the
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clinical issues in the old age group with AMI; namely,
presenting complaints tend to be atypical and ECG findings
tend to be nondiagnostic. A frequent ECG finding is ST
segment depression with the development of non-Q-wave
infarct (13). As confirmed by this report, these “atypical”
features (for young patients!) do not connote a lower
mortality rate in the elderly. We must improve our recog-
nition of the clinical presentation of AMI in the elderly;
“atypical” presentations in reference to symptoms and ECG
findings should be considered frequent and the norm. The
clear message from the work of Shlipak et al. (8) is the need
to lower the diagnostic threshold for considering AMI
when LBBB is present, especially in the older patient.
Can AMI be diagnosed by ECG when LBBB is present?
Better tests for AMI that can be immediately available in
the emergency department are being intensively investigated
but, in the near future, the 12-lead ECG will remain the
primary diagnostic tool to assess the presence of epicardial
coronary arterial thrombosis and make the decision for
reperfusion therapy.
With LBBB, the course of ventricular activation is
altered, which secondarily affects ventricular repolariza-
tion. The QRS, ST-segment and T wave of the ECG are
always affected by LBBB. More often than not, the early
signs of AMI will be obscured by the changes due to the
conduction abnormality. The prevalence of LBBB and
other cardiac conduction abnormalities increases with
age. While LBBB due to “sclerodegenerative” disease
(14 –16) or senile amyloidosis (17) can occur in the
absence of other structural heart disease or cardiac
symptoms (18), detailed clinicopathologic studies (14 –
17) show that LBBB increases in the elderly and is more
often associated with advanced cardiac disease of several
types. Thus, LBBB is a marker both of age and severe
heart disease but not exclusively coronary disease.
Multiple studies have evaluated the ability to diagnose
AMI when LBBB is present (19–24). The work of Sgar-
bossa et al. (24) is instructive in this regard. They developed
diagnostic criteria for AMI when LBBB was present using
data from the GUSTO-1 Trial (the derivation or training
sample) and from a control population with LBBB and
stable ischemic heart disease (the validation sample). Three
ECG criteria based on ST segment displacement were
found to have independent diagnostic value (see legend of
the Fig. 1). The three criteria were assigned index scores and
incorporated in a diagnostic algorithm. This algorithm was
found to have a sensitivity of 78% and a specificity of 90%
in the derivation/training sample. The diagnostic specificity
remained high, 96%, but the sensitivity was quite low, 36%,
when applied to the validation sample, a small group of 45
patients. In an earlier report, Shlipak et al. (25) tested the
Sgarbossa algorithm and other ECG criteria for myocardial
infarctions in patients with LBBB and found that none
effectively distinguished the patients with myocardial infarc-
tion from those with other diagnoses. A possible explana-
tion for these differing results is that the Sgarbossa algo-
rithm was derived and validated in a cohort of patients with
LBBB from the GUSTO-1 Trial, which represented only
0.5% of the 26,003 patients enrolled in the trial (26). This
low percentage of LBBB in AMI suggests that the cohort
studied by Sgarbossa et al. (24) was highly selected and may
not be representative of the universe of patients with this
combination of abnormalities.
The reported studies of LBBB-AMI suggest that an
unknown, albeit small, subset of patients have ECG
changes that are indicative of AMI and in this group these
findings could lead to immediate fibrinolytic therapy. More
research is needed to confirm, refine and determine the
frequency of ECG findings of LBBB that may indicate
AMI. For example, included in such studies would be the
evaluation of serial ECGs, taken over a brief period of 30 to
40 min, to determine if fluctuating repolarization changes
may enhance the sensitivity of the 12-lead ECG since
repolarization changes are dynamic during the early course
of transmural myocardial infarction.
What might be done to resolve this issue? No simple
approach to resolution is feasible. What can be done
immediately and what must be done in order to provide
better care is to have a much lower threshold for the
suspicion of AMI in all elderly patients with nonspecific
cardiac complaints, particularly dyspnea, but with a wide
variety of complaints, which are common in AMI in the
elderly. When LBBB is present, the suspicion of AMI
should be increased, efforts should be made to obtain
previous ECGs and particular attention should be paid to
subtle changes in repolarization, which will lead to more
definitive tests.
In patients in whom the suspicion of AMI is high,
reperfusion therapy should be seriously considered because
of the high mortality of AMI-LBBB in elderly patients.
Obviously, a highly individualized approach is needed with
careful consideration of the patient’s general health activity
status and co-morbidity (26). If fibrinolytic therapy is
selected, streptokinase has been demonstrated in all studies
to have a lower risk of cerebral hemorrhage—the most
dreaded complication of therapy—which increases in the
elderly population (27,28). In addition, decision analysis
using the GISSI-1 database has demonstrated fibrinolysis to
be cost effective even when the probability of diagnosis of
AMI is relatively low in elderly patients because the mor-
tality is so high and the mortality benefit was great (33% to
29% reduction) (29).
In patients with LBBB in whom the diagnosis is probable
but not certain, emergency cardiac catheterization both for
diagnosis and to plan management is justified. Achieving
immediate reperfusion with a catheter-based intervention in
this setting is almost certainly more effective than throm-
bolytic therapy and avoids the risk of central nervous system
(CNS) hemorrhage. The NRMI-2 registry emphasizes the
approach that could be utilized to clarify the problem.
Registries are powerful tools to assess these issues. A large
registry of patients with LBBB who are evaluated in
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emergency departments with a variety of complaints could
constitute the study sample. The protocol for such a study
would include clinical presentation, ECG findings (partic-
ularly study of serial ECGs) and the management selected,
as well as outcomes. As in any good registry study, defini-
tions would have to be agreed on and used in a prescriptive
fashion.
The Venn diagram (Fig. 1) provides a framework to
discuss the multiple facets of the problem and management
approaches. It is not intended to be prescriptive but to
emphasize the fact that multiple permutations exist that call
for fastidiously collected data to better define management
strategies. If the Sgarbossa criteria were confirmed, patients
in subsets A, B and C would proceed to revascularization.
Subsets D, E and F pose the dilemma emphasized in the
current Shlipak et al. (8) article. Patients in the D subgroup
were more likely (13.2%) than patients in the E subgroup
(2.6%) to receive reperfusion therapy, but both sets had
unacceptably low attempts at reperfusion. Patients in the F
subset would represent those with AMI who had confusing
symptoms that were primarily not cardiac, such as fatigue,
“generally not well,” CNS manifestations, among others—
presentations that are common in elderly patients with
AMI. Subset G represents patients who have an acute
coronary syndrome without myocardial necrosis but who
require energetic workup and care to prevent AMI. Subset
H includes a highly problematic group of patients, some of
whom would have acute coronary syndromes. The remain-
ing LBBB patients (large circle) will represent a wide array
of clinical entities including stable or unstable coronary
syndromes.
Since LBBB patients as a group are older, co-morbidity
and frailty will be deterrents to aggressive evaluations and
workup. However, in the absence of contraindications,
urgent coronary arteriography would provide the pathway to
better treatment in many patients. Although the use of
arteriography in the elderly is increasing (30,31), currently
in the U.S. the procedure is used more frequently in young,
low-risk patients with AMI in whom the benefit will not be
great (32,33). Acute myocardial infarction in the elderly
with associated frailty and co-morbidity will always require
highly individualized, thoughtful clinical judgment. The
heterogeneity of the elderly and the heterogeneity of the
emergency department patients with LBBB assure that
randomized control trials will contribute little to the reso-
lution of these problems (34). A carefully conceived registry
study, as the current NRMI-2 study illustrates, can be an
effective approach utilizing the scheme outlined in the Venn
diagram (35).
Shlipak et al. (8) have provided valuable information
on an important problem, LBBB in patients with AMI,
with their analysis of the extraordinary NRMI-2 database
of .29,000 patients. By focusing attention on the current
management of this problematic group of patients, they
expose a much larger problem in cardiology practice;
namely the gross underutilization of reperfusion therapy
in the elderly population with AMI. In this high-risk
population, not only are better ECG criteria and other
diagnostic approaches needed to diagnose AMI in the
emergency department, but it is reasonable to use emer-
gent coronary arteriography more frequently for diagnosis
and to plan management. Since randomized control trials
will not be done in the elderly, the registry method
should be used and could help unravel difficult manage-
ment problems. With .70 million baby boomers soon to
enter old age, the issues brought into focus by Shlipak et
al. (8) and commented on in this editorial will become
even more pressing.
Addendum. A recent publication, (Thieman DR, Coresh
J, Schulman S, et. al. Lack of benefit of intravenous
thrombolysis in patients with myocardial infarction who are
older than 75 years, Circulation 2000;101:2239–2246 2000)
reports the lack of benefit and potential adverse effects of
fibrinolytic therapy in 7,864 Medicare patients, age 65 to 86
years, with the primary discharge diagnosis of acute myo-
cardial infarction. This observational study needs to be
confirmed but the data presented further emphasizes the
complexities of the issues involved in elderly patients with
acute myocardial infarction and makes catheter-based reper-
fusion procedures, as discussed in this editorial, more
appealing.
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Figure 1. The Venn diagram depicts the universe of patients with LBBB
evaluated in the emergency department and the relationships between
LBBB and AMI. Categories/subsets emphasize the wide range of possi-
bilities that exist. The Venn diagram is discussed in the text.
The LBBB with new ST displacement subset emphasizes there may be
ECG changes helpful in diagnosing AMI. The scoring system of Sgarbossa
is one approach. ST-segment elevation .1 mm and concordant with QRS
complex, 5 points; ST-segment depression .1 mm in lead V1, V2, and V3,
3 points; ST-segment elevation .5 mm and discordant with QRS
complex, 2 points; an ECG score of 3 is used to diagnose AMI; 2 is
suspicious for AMI.
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